Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Infant Study of Inhaled Saline in Cystic Fibrosis (ISIS)

This study has been completed.
Cystic Fibrosis Foundation Therapeutics
Information provided by (Responsible Party):
CF Therapeutics Development Network Coordinating Center Identifier:
First received: July 1, 2008
Last updated: February 11, 2013
Last verified: February 2013